NOTE 10 - GOING CONCERN

12 Months Ended

Dec. 31, 2013

Going Concern Disclosure [Abstract]

Going Concern Disclosure [Text Block]

NOTE 10 - GOING CONCERN

The Company’s consolidated financial statements are prepared using U.S. GAAP which assumes an entity is a going concern and contemplates the realization of assets and the settlement of liabilities in the normal course of business.  The Company has incurred significant recurring losses from its inception through December 31, 2013, which have resulted in an accumulated deficit of $31,421,984 as of December 31, 2013.  The Company has minimal cash, has a working capital deficit of $3,333,251, and a total stockholders’ deficit of $3,107,800 as of December 31, 2013. The Company has relied almost exclusively on debt and equity financing to sustain its operations.  Accordingly, there is substantial doubt about its ability to continue as a going concern.

Continuation of the Company as a going concern is dependent upon obtaining additional capital and ultimately, upon the Company attaining profitable operations.  The Company will require a substantial amount of additional funds to complete the continued development of its products, product manufacturing, and to fund additional losses, until revenues are sufficient to cover the Company’s operating expenses. If the Company is unsuccessful in obtaining the necessary additional funding, it will most likely be forced to substantially reduce or cease operations.

The Company believes that it will need approximately $1,500,000 during the next 12 months for continued production manufacturing and related activities, research, development, marketing activities, as well as for general corporate purposes.

During 2013, the Company raised a total of $1,413,250 through the sale of 33,284,269 shares of common stock at prices ranging from $0.03 to $0.06 per share, which funds have been used to keep the Company current in its public reporting obligations and to pay certain other corporate obligations including the costs of development for its hospital disinfection system.  Subsequent to December 31, 2013, through the date of this report, the Company raised a total of $50,000 through the sale of 1,000,000 shares of common stock at a price of $0.05 per share.  The Company believes it can raise additional funds from certain investors who have purchased shares from 2009 through 2013, although there is no assurance that these investors will purchase additional shares.

The ability of the Company to continue as a going concern is dependent on its ability to successfully accomplish the plan described in the preceding paragraphs and eventually attain profitable operations.  The consolidated financial statements do not include any adjustments relating to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might result from the outcome of this uncertainty.